Dr. Alun Tanner has more than 30 years of experience in all phases of pharmaceutical drug development including the support of M&A activities. Currently an independent consultant, he advises CROs, biotech, and pharma companies on how to maintain compliance and implement industry best quality practices in the complex regulatory environment of pharmacovigilance.